Loading...

Fosamprenavir plus Ritonavir Increases Plasma Ketoconazole and Ritonavir Exposure, while Amprenavir Exposure Remains Unchanged

Plasma ketoconazole (KETO), amprenavir (APV), and ritonavir (RTV) pharmacokinetics were evaluated in 15 healthy subjects after being treated with KETO at 200 mg once daily (QD), fosamprenavir (FPV)/RTV at 700/100 mg twice daily (BID), and then KETO at 200 mg QD plus FPV/RTV at 700/100 mg BID in this...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Wire, Mary B., Ballow, Charles H., Borland, Julie, Shelton, Mark J., Lou, Yu, Yuen, Geoffrey, Lin, Jiang, Lewis, Eric W.
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology 2007
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1932497/
https://ncbi.nlm.nih.gov/pubmed/17517848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00008-07
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!